HISTAFED COMPOUND LINCTUS

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

şimdi satın al

Aktif bileşen:

CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLRIDE

Mevcut itibaren:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD

ATC kodu:

R06AX07

Farmasötik formu:

SYRUP

Kompozisyon:

CODEINE PHOSPHATE 5 MG / 5 ML; PSEUDOEPHEDRINE HYDROCHLORIDE 30 MG / 5 ML; TRIPROLIDINE HYDROCHLRIDE 1.25 MG / 5 ML

Uygulama yolu:

PER OS

Reçete türü:

Required

Tarafından üretildi:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL

Terapötik grubu:

TRIPROLIDINE

Terapötik alanı:

TRIPROLIDINE

Terapötik endikasyonlar:

Antitussive syrup for the symptomatic relief of cough accompanied by nasal congestion and congestion of the upper respiratory tract.

Yetkilendirme tarihi:

2022-09-30

Bilgilendirme broşürü

                                107378010
0317F
PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS (PREPARATIONS) - 1986
The medicine is dispensed with a doctor’s prescription only
HISTAFED COMPOUND LINCTUS
SYRUP
Each 5 ml contains:
Triprolidine HCl
1.25 mg
Pseudoephedrine hydrochloride 30 mg
Codeine phosphate
5 mg
For inactive ingredients in the preparation – see section 6
“Further
Information”.
READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE MEDICINE.
This
leaflet contains concise information about the medicine. If you have
further
questions, refer to the doctor or pharmacist.
This medicine has been prescribed for you. Do not pass it on to
others. It may
harm them, even if it seems to you that their medical condition is
similar.
The medicine is not intended for children under the age of 12.
The medicine is not recommended for children and adolescents aged
12-18
suffering from respiratory problems.
The medicine is not intended for those who are known to produce
significant
quantities of morphine following a dose of codeine (they belong to the
group
of “CYP2D6 ultra-rapid metabolizers”), since they are at increased
risk of
suffering from severe side effects as a result of taking codeine.
1. WHAT IS THE MEDICINE INTENDED FOR?
Antitussive when accompanied with nasal and upper respiratory tract
congestion.
THERAPEUTIC GROUP:
Triprolidine is an H1 antihistamine.
Pseudoephedrine is an alpha agonist.
Codeine Phosphate is an opiate cough suppressant.
2. BEFORE USING THE MEDICINE DO NOT USE THE MEDICINE IF:
∙ You are sensitive to the active ingredients or to other members of
the
opiate family or to any of the additional ingredients contained in the
medicine (see section 6).
∙ Do not use in children under the age of 12.
∙ The medicine is not intended for those who are known to produce
significant quantities of morphine following a dose of codeine (they
belong
to the group of “CYP2D6 ultra-rapid metabolizers”), since they are
at
increased risk of suffering from severe side effects as a result of
ta
                                
                                Belgenin tamamını okuyun
                                
                            

Diğer dillerdeki belgeler

Bilgilendirme broşürü Bilgilendirme broşürü Arapça 22-05-2017
Bilgilendirme broşürü Bilgilendirme broşürü İbranice 22-05-2017

Belge geçmişini görüntüleyin